Skip to main content

Table 3 Changes in serum ferritin and TSAT (safety-analysis set)

From: Effects of ferric citrate hydrate in patients with chronic kidney disease and heart failure: subgroup analysis of a long-term, real-world, post-marketing surveillance study

  

Patients with heart failure

Patients without heart failure

Time after treatment initiation

Time after treatment initiation

12 weeks

36 weeks

52 weeks

104 weeks

12 weeks

36 weeks

52 weeks

104 weeks

Serum ferritin [ng/mL]

 HD

n

75

59

56

40

636

568

551

442

 

Change from baseline, mean (SD)

33.01 (62.11)

90.98 (107.40)

67.17 (89.50)

97.16 (117.34)

39.32 (80.57)

81.86 (111.33)

89.47 (120.88)

90.70 (134.59)

 

95% CI

18.72–47.30

62.99–118.97

43.20–91.14

59.63–134.68

33.05–45.59

72.68–91.03

79.36–99.59

78.11–103.28

 PD

n

20

17

13

6

76

63

61

37

 

Change from baseline, mean (SD)

80.09 (120.73)

158.64 (96.72)

194.21 (82.88)

221.82 (145.40)

35.22 (83.44)

132.91 (136.26)

128.82 (125.62)

194.46 (179.09)

 

95% CI

23.59–136.59

108.91–208.36

144.12–244.29

69.23–374.41

16.15–54.29

98.59–167.23

96.65–161.00

134.75–254.17

 ND

n

62

47

37

31

229

171

129

65

 

Change from baseline, mean (SD)

43.10 (81.54)

68.06 (94.23)

97.47 (143.11)

104.88 (113.48)

40.95 (84.50)

99.75 (123.56)

102.23 (105.22)

140.21 (153.34)

 

95% CI

22.39–63.80

40.40–95.73

49.75–145.18

63.25–146.50

29.95–51.95

81.10–118.40

83.90–120.56

102.21–178.20

TSAT [%]

 HD

n

70

57

53

33

696

629

605

469

 

Change from baseline, mean (SD)

12.79 (15.29)

11.17 (14.71)

8.27 (15.39)

8.24 (17.36)

9.57 (14.96)

9.04 (14.13)

9.50 (15.18)

9.36 (15.80)

 

95% CI

9.15–16.44

7.27–15.07

4.02–12.51

2.08–14.39

8.46–10.68

7.93–10.15

8.29–10.71

7.93–10.80

 PD

n

20

17

14

5

78

62

55

36

 

Change from baseline, mean (SD)

9.55 (17.60)

15.01 (14.77)

16.55 (13.82)

19.10 (7.85)

4.96 (15.61)

9.67 (13.71)

7.85 (16.87)

8.19 (22.73)

 

95% CI

1.31–17.78

7.42–22.60

8.57–24.53

9.36–28.84

1.44–8.48

6.19–13.15

3.29–12.41

0.50–15.88

 ND

n

53

41

33

29

192

142

103

60

 

Change from baseline, mean (SD)

5.85 (13.90)

11.52 (12.32)

15.58 (11.25)

12.29 (12.02)

5.21 (13.16)

8.27 (15.50)

8.06 (14.39)

8.01 (15.59)

 

95% CI

2.02–9.69

7.63–15.41

11.59–19.57

7.72–16.86

3.34–7.09

5.70–10.84

5.24–10.87

3.98–12.03

  1. HD, hemodialysis group; PD, peritoneal dialysis group; ND, non-dialysis-dependent group; SD, standard deviation; CI, confidence interval